首页 工具
登录
购物车

搜索结果

Search Results for " patient-derived "
Targets Recommended: Transferase

24

抑制剂 & 化合物

1

天然产物

1

化合物库

1

重组蛋白

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name
L4600 植物来源化合物库

3048 compounds
3048 个植物来源天然产物的独特集合,来自277类植物的精心之选;

化合物库

植物来源化合物库
Cat.No: L4600
Compounds: 3048
Cat. No. Product Name Target Signaling Pathways
T11282 FGTI-2734

Transferase Metabolism
FGTI-2734 是 有效的RAS C-末端法尼基转移酶 (FT) 和香叶烯基转移酶-1 (GGT-1) 抑制剂,IC50s 分别为 250 nM 和 520 nM。 它可以阻断 KRAS 的膜定位,从而解决 KRAS 耐药性问题,并抑制突变的 KRAS 胰腺肿瘤。
T9167 PF-9363

CTX-3648

Histone Acetyltransferase Chromatin/Epigenetic
PF-9363 (CTX-3648) 是一种有效且高选择性的 KAT6A/KAT6B 抑制剂,可用于癌症研究。
T2069L TH287 hydrochloride

DNA/RNA Synthesis; MTH1 Cell Cycle/Checkpoint; DNA Damage/DNA Repair
TH287 hydrochloride 是一种选择性MTH1抑制剂,IC50值为 0.8 nM。它可用于治疗癌症的研究。
T35822 CAY10722

Others Others
CAY10722 is an inhibitor of sirtuin 3 (SIRT3), a class III HDAC (71% inhibition at 200 μM). SIRT3 is involved in modulating metabolic homeostasis as a NAD+-dependent protein deacetylase in the mitochondria. SIRT3 functions as either an oncogene or tumor suppressor, depending on cancer cell type. High SIRT3 expression in patient-derived esophageal cancer tissues is associated with shorter survival and, in mice, downregulation leads to a lower tumor load. In contrast, low SIRT3 expression in patie...
T83716 KSL-128114 TFA

Ac-rRrGrKkRrSHWX1X2DI-OH (X1=tert-Leucine; X2=Cyclohexylglycine)

KSL-128114是一种对膜调节剂syntenin的肽抑制剂(Ki = 300 nM)。它能够依赖浓度降低A2058黑色素瘤和患者来源的多形性胶质母细胞瘤(GBM)细胞的存活率。在使用患者来源的GBM细胞并在颅内植入前用KSL-128114培养的患者衍生异种移植(PDX)小鼠模型中,KSL-128114(50 µM)提高了动物的存活时间。
T11282L FGTI-2734 mesylate (1247018-19-4 free base)

FGTI-2734 mesylate

Others Others
FGTI-2734 mesylate, a RAS C-terminal mimetic compound with dual farnesyl transferase (FT) and geranylgeranyl transferase-1 (GGT) inhibitory activities (IC50s of 250 nM and 520 nM for FT and GGT, respectively), mitigates KRAS resistance by preventing its membrane localization, effectively impeding mutant KRAS patient-derived pancreatic tumors.
T70134 L-778123 Dihydrochloride

Others Others
L-778123 is an inhibitor of FPTase and GGPTase-I, which was developed in part because it can completely inhibit Ki-Ras prenylation. The combination of L-778,123 and radiotherapy at dose level 1 showed acceptable toxicity in patients with locally advanced pancreatic cancer. Radiosensitization of a patient-derived pancreatic cancer cell line was observed.
T35670 Miro1 Reducer

Others Others
Promotes proteasomal degradation of Miro1 (mitochondrial Rho GTPase 1). Reduces Miro1 levels in fibroblasts from Parkinson's disease (PD) patients (IC50 = 7.8 μM). Exhibits no significant effect on related outer mitochondrial membrane protein Mitofusin. Reduces stress-induced degeneration of dopaminergic neurons derived from PD patient iPSCs. Rescues age-dependent neuronal loss and prolongs lifespan in fly PD models.
T66481 TG-693

Others Others
TG693, an orally available inhibitor of CLK1, promotes the skipping of the endogenous mutated exon 31 in Duchenne muscular dystrophy (DMD) patient-derived cells and increased the production of the functional exon 31-skipped dystrophin protein.
T36275 xStAx-VHLL

Selective peptide-based β-catenin Degrader. Comprises a β-catenin-targeted stapled peptide, xStAx, linked to a VHL-binding peptide. Reduces β-catenin levels in HEK293T cells and colorectal cancer cell lines. Selectively degrades β-catenin over other Wnt signaling pathway components. Inhibits tumor growth in APCmin/+ mice, with constitutively active Wnt signaling, and reduces survival of patient-derived colorectal cancer cell organoids.
T79461 YK-029A

EGFR Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors
YK-029A为口服活性的EGFR突变抑制剂,特异性针对EGFRT790M及EGFRex20ins。该化合物在PDX模型上对肿瘤展现良好的抑制效果,显示出明显的抗肿瘤活性。
T73429 VT02956

Others Others
VT02956 是一种LATS 抑制剂 (IC50: LATS1 为 0.76 nM,LATS2 为 0.52 nM)。VT02956 靶向Hippo 信号通路。VT02956 抑制 ER+ 乳腺癌细胞系和患者来源的肿瘤类器官的生长和 ESR1 表达。
T62676 DS89002333

Others Others
DS89002333 是一种强效的、口服具有活力的 PRKACA 抑制剂 (IC50: 0.3 nM)。DS89002333 在表达 DNAJB1-PRKACA 融合基因的 FL-HCC 患者源性异种移植模型中具有良好的抗肿瘤作用。DS89002333 能够用于研究纤维化肝细胞癌 (FL-HCC)。
T35481 DD 03-171

Others Others
Potent and selective BTK Degrader (IC50 = 5.1 nM); degrades BTK in a proteasome- and CRBN-dependent manner. Suppresses BTK signaling and proliferation in mantle cell lymphoma (MCL) cells by degrading BTK, IKFZ1, and IKFZ3 (3 validated targets in B-cell malignancies). Also degrades Ibrutinib (Cat. No. 6813) -resistant C481S-BTK mutant cancer cells. Exhibits no binding against a panel of 468 kinases at 1 μM. Reduces tumor burden and extends survival in lymphoma patient-derived xenograft models.
T36451 1,2-Dipalmitoyl-sn-glycero-3-PE-N-(cap biotin) (sodium salt)

1,2-Dipalmitoyl-sn-glycero-3-PE-N-(cap biotin) (sodium salt),biotin-cap-DPPE

Others Others
1,2-Dipalmitoyl-sn-glycero-3-PE-N-(cap biotin) is a biotinylated phospholipid. It has been used in PEGylated polyamidoamine-dendrimer-conjugated supported lipid bilayers (SLB) to isolate circulating tumor cells and tumor cell microembolis from patient-derived blood by antibody-coated microfluidics. [1] It has also been used as a component of SLBs to detect protein-ligand binding with ortho-conjugated Texas Red DHPE. [2] In addition, 1,2-dipalmitoyl-sn-glycero-3-PE-N-(cap biotin) has been used i...
T76791 Seribantumab

Seribantumab (MM 121) 是一种完全人 IgG2单克隆抗体,靶向 HER3。Seribantumab 阻断 ErbB 家族成员及其下游信号的激活。Seribantumab 在体内、外抑制乳腺癌、肺癌和卵巢癌患者源性癌症模型中神经调节蛋白 (NRG1) 融合依赖的肿瘤发生。
T78877 MTX-241F

EGFR Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors
MTX-241F是一种选择性小分子抑制剂,针对EGFR和PI3激酶家族。其具备穿透血脑屏障的能力,能够持续控制肿瘤生长。在来源于患者的DIPG神经球中,MTX-241F展示了与放射疗法协同增效的特性,适用于研究弥漫性内源性桥脑胶质瘤(DIPG)。
T73558 W1131

Others Others
W1131 是一种有效的STAT3抑制剂,可引发铁死亡。W1131 在胃癌皮下异种移植模型、类器官模型和 PDX 模型中抑制癌症进展。W1131 有效减轻癌细胞对 5-FU 化学耐药性。W1131 调节细胞周期、DNA 损伤反应和氧化磷酸化,包括IL6-JAK-STAT3通路和铁死亡 (ferroptosis) 通路。
T83912 HR68

PP21

Others Others
HR68是一种抗癌化合物,是过氧化物酶体增殖物激活受体(PPAR)激动剂非诺贝酯的衍生物。它能降低LN-229胶质母细胞瘤细胞的存活率(IC50 = 1.17 µM)。HR68能够穿越血脑屏障,在对替莫唑胺耐药的原位患者衍生的异种移植(PDX)小鼠胶质母细胞瘤模型中发挥作用。
T77012 Flotetuzumab

Flotetuzumab (MGD006; S80880) 是一种双特异性 CD123/CD3双亲和再靶向 (DART) 抗体。Flotetuzumab 通过同时结合靶细胞的 CD123和效应 T 细胞的CD3,而重新激活 T 细胞,导致 T 细胞介导的靶细胞的细胞毒性。Flotetuzumab 对小鼠中急性髓系白血病 (AML) 患者来源异种移植物 (PDX) 模型具有抑制效力。
T79405 PARP1-IN-15

PARP Chromatin/Epigenetic; DNA Damage/DNA Repair
PARP1-IN-15(Compound 6)是一款针对PARP1的抑制剂,能够抑制坦聚合酶(TNKS)并促进DNA双链断裂损伤。该化合物在诱导肿瘤细胞凋亡(apoptosis)方面具有显著作用,且在三阴性乳腺癌(TNBC)细胞及来源于TNBC患者的类器官中显示出抗癌活性,适用于探究BRCA1突变状态下的TNBC研究。
T36235 5-Chlorouracil

Others Others
5-Chlorouracil is a chlorinated derivative of the pyrimidine nucleoside base uracil . In vivo, it is converted into chlorodeoxyuridine, which is mutagenic and genotoxic.1 Uracil is chlorinated at the 5 position in a cell-free myeloperoxidase, peroxide, and chloride system in which hypochlorous acid is formed.2 5-Chlorouracil has been found in human neutrophils stimulated with phorbol 12-myristate 13-acetate in vitro and in inflammatory human exudate isolated from sites of superficial infection. ...
T83930 SJ 11646

Others Others
SJ11646是一种高效的LCK(淋巴细胞特异性蛋白酪氨酸激酶)降解剂(PROTAC;DC50= 0.00838 pM)。该化合物由Dasatinib作为LCK配体,以及基于苯基谷氨酰亚胺的cereblon结合体组成。它在体外对LCK激活的T细胞急性淋巴细胞白血病(T-ALL)细胞株和初级白血病样本展现出细胞毒性。在体内,SJ11646在源自患者的T-ALL异种移植模型中显示出抗白血病效果。
T35940 Darinaparsin

Dimethylarsinic glutathione,Darinaparsin

Others Others
Darinaparsin is a dimethylated arsenic linked to glutathione. It is cytotoxic to DU145, LNCaP, and PC3 prostate cancer cells (IC50s = 5-10 &#181M) and patient-derived primary prostate cancer cells (IC50s = 2.5-20 &#181M), as well as Jurkat T cell lymphoma and L540 Hodgkin lymphoma cells (IC50s = 2.7 and 1.3 &#181M, respectively). [1][2] It decreases the tumor-initiating subpopulation in DU145 and PC3 cells and halts the cell cycle in the G2/M phase. Darinaparsin decreases transcription of Gli-2,...

化合物

FGTI-2734
Cat.No: T11282
Synonym:
Target: Transferase
PF-9363
Cat.No: T9167
Synonym: CTX-3648
Target: Histone Acetyltransferase
TH287 hydrochloride
Cat.No: T2069L
Synonym:
Target: DNA/RNA Synthesis, MTH1
CAY10722
Cat.No: T35822
Synonym:
Target: Others
KSL-128114 TFA
Cat.No: T83716
Synonym: Ac-rRrGrKkRrSHWX1X2DI-OH (X1=tert-Leucine; X2=Cyclohexylglycine)
Target:
FGTI-2734 mesylate (1247018-19-4 free base)
Cat.No: T11282L
Synonym: FGTI-2734 mesylate
Target: Others
L-778123 Dihydrochloride
Cat.No: T70134
Synonym:
Target: Others
Miro1 Reducer
Cat.No: T35670
Synonym:
Target: Others
TG-693
Cat.No: T66481
Synonym:
Target: Others
xStAx-VHLL
Cat.No: T36275
Synonym:
Target:
YK-029A
Cat.No: T79461
Synonym:
Target: EGFR
VT02956
Cat.No: T73429
Synonym:
Target: Others
DS89002333
Cat.No: T62676
Synonym:
Target: Others
DD 03-171
Cat.No: T35481
Synonym:
Target: Others
1,2-Dipalmitoyl-sn-glycero-3-PE-N-(cap biotin) (sodium salt)
Cat.No: T36451
Synonym: 1,2-Dipalmitoyl-sn-glycero-3-PE-N-(cap biotin) (sodium salt),biotin-cap-DPPE
Target: Others
Seribantumab
Cat.No: T76791
Synonym:
Target:
MTX-241F
Cat.No: T78877
Synonym:
Target: EGFR
W1131
Cat.No: T73558
Synonym:
Target: Others
HR68
Cat.No: T83912
Synonym: PP21
Target: Others
Flotetuzumab
Cat.No: T77012
Synonym:
Target:
PARP1-IN-15
Cat.No: T79405
Synonym:
Target: PARP
5-Chlorouracil
Cat.No: T36235
Synonym:
Target: Others
SJ 11646
Cat.No: T83930
Synonym:
Target: Others
Darinaparsin
Cat.No: T35940
Synonym: Dimethylarsinic glutathione,Darinaparsin
Target: Others
Cat. No. Product Name Target Signaling Pathways
T83281 6-(1-Hydroxyethyl)-5,6-dihydrochelerythrine

6-(1-Hydroxyethyl)-5,6-dihydrochelerythrine 显著影响细胞器特性,涉及早期内体、线粒体及自噬体(源自帕金森病患者的嗅觉细胞)。

天然产物

6-(1-Hydroxyethyl)-5,6-dihydrochelerythrine
Cat.No: T83281
Synonym:
Target:
Cat. No. Product Name Species Expression System
TMPK-00761 B2M/beta 2-Microglobulin Protein, Mouse, Recombinant (hFc)

B2M/β 2-Microglobulin,Beta-2-microglobulin,B2M,β-2-microglob...

Mouse HEK293 Cells
The genetic and functional analysis of β2-microglobulin (B2M), a component of the HLA class-I complex.Acquired homozygous loss of B2M that caused lack of cell-surface HLA Class I expression in the tumor and a matched patient-derived xenograft (PDX). Downregulation of B2M was also found in two additional PDXs established from ICI-resistant tumors.

重组蛋白

B2M/beta 2-Microglobulin Protein, Mouse, Recombinant (hFc)
Cat.No: TMPK-00761
Species: Mouse
Expression System: HEK293 Cells
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼